Robert E. Hoffman

2012

In 2012, Robert E. Hoffman earned a total compensation of $1.4M as Senior Vice President, Finance and Chief Financial Officer at Arena Pharmaceuticals, a 179% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$196,200
Option Awards$692,179
Salary$327,000
Stock Awards$133,050
Other$15,636
Total$1,364,065

Hoffman received $692.2K in option awards, accounting for 51% of the total pay in 2012.

Hoffman also received $196.2K in non-equity incentive plan, $327K in salary, $133.1K in stock awards and $15.6K in other compensation.

Rankings

In 2012, Robert E. Hoffman's compensation ranked 4,917th out of 11,487 executives tracked by ExecPay. In other words, Hoffman earned more than 57.2% of executives.

ClassificationRankingPercentile
All
4,917
out of 11,487
57th
Division
Manufacturing
1,720
out of 4,253
60th
Major group
Chemicals And Allied Products
407
out of 1,203
66th
Industry group
Drugs
261
out of 925
72nd
Industry
Pharmaceutical Preparations
206
out of 700
71st
Source: SEC filing on April 29, 2015.

Hoffman's colleagues

We found four more compensation records of executives who worked with Robert E. Hoffman at Arena Pharmaceuticals in 2012.

2012

Jack Lief

Arena Pharmaceuticals

Chief Executive Officer

2012

Steven Spector

Arena Pharmaceuticals

General Counsel

2012

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2012

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

In-depth

You may also like